PTC-672

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePTC-672
Drug Alias Nameantibacterial program (PTC Therapeutics)PTC-QZPTC-672PTC-QJ
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsTranslation pathway modulatorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPtc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A